Shares of Molina Healthcare, Inc (NYSE:MOH - Get Free Report) have been given a consensus recommendation of "Hold" by the eighteen research firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $213.88.
Several equities research analysts have recently weighed in on MOH shares. UBS Group increased their target price on shares of Molina Healthcare from $202.00 to $225.00 and gave the company a "neutral" rating in a research note on Friday, October 23rd. Royal Bank Of Canada lifted their price target on shares of Molina Healthcare from $218.00 to $222.00 and gave the stock a "sector perform" rating in a research note on Friday, October 23rd. Zacks Research downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Monday, October 12th. Barclays cut their price target on shares of Molina Healthcare from $180.00 to $178.00 and set an "underweight" rating on the stock in a report on Friday, October 23rd. Finally, Cantor Fitzgerald reissued a "neutral" rating on shares of Molina Healthcare in a research report on Friday, October 9th.
Get Our Latest Analysis on MOH
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Molina Healthcare in the second quarter valued at approximately $1,503,052,000. Wellington Management Group LLP boosted its stake in Molina Healthcare by 11.9% in the 2nd quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company's stock worth $289,810,000 after purchasing an additional 135,247 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Molina Healthcare by 23.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company's stock worth $185,929,000 after purchasing an additional 267,121 shares in the last quarter. Manning & Napier Advisors LLC acquired a new stake in Molina Healthcare in the 2nd quarter worth approximately $152,339,000. Finally, Bank of New York Mellon Corp purchased a new stake in Molina Healthcare during the 2nd quarter worth approximately $86,138,000. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Stock Performance
NYSE MOH opened at $204.88 on Friday. The stock has a market capitalization of $10.69 billion, a PE ratio of -213.41, a P/E/G ratio of 12.08 and a beta of 0.78. The business has a 50 day simple moving average of $200.62 and a two-hundred day simple moving average of $184.81. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.69. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, topping analysts' consensus estimates of $0.79 by $0.10. The business had revenue of $11.08 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The business's revenue was down 3.4% on a year-over-year basis. During the same period last year, the company posted $1.84 EPS. On average, research analysts predict that Molina Healthcare will post 5.30 EPS for the current fiscal year.
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.
The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.